Romidepsin and lenalidomide‐based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
Mehta‐Shah, Neha, Lunning, Matthew A., Moskowitz, Alison J., Boruchov, Adam M., Ruan, Jia, Lynch, Peggy, Hamlin, Paul A., Leonard, John, Matasar, Matthew J., Myskowski, Patricia L., Marzouk, Evan, Nair, Sumithra, Sholklapper, Tamir, Minnal, Veena, Palomba, Maria L., Vredenburgh, James, Kumar, Anita, Noy, Ariela, Straus, David J., Zelenetz, Andrew D., Schoder, Heiko, Rademaker, Jurgen, Schaffer, Wendy, Galasso, Natasha, Ganesan, Nivetha, Horwitz, Steven M.
Published in American journal of hematology (01.10.2021)
Published in American journal of hematology (01.10.2021)
Get full text
Journal Article